California Hepatitis C Task Force

01/23/2026

Congressman Raul Ruiz, MD and Congressman David G. Valadao, thank you for helping lead the to House passage. This milestone brings us closer to a new era of cancer detection. We look forward to seeing the Senate finish the job!

01/21/2026

For people impacted by Hep C, cancer risk is real—and early detection matters. Congressman Vince Fong, thank you for supporting the . We're rooting for you to get this done!

01/21/2026

A Stanford Medicine study shows promising results curing mice with Type 1 diabetes using an “immune system reset”.
Read more here:

An “immune system reset” cured autoimmune, or Type 1, diabetes in mice in a Stanford Medicine study. The approach may be useful for other autoimmune conditions as well as organ transplants.

01/20/2026

Over 400,000 people in the Central Valley live with chronic HCV, increasing their risk of cancer and late-stage diagnosis, but early detection can change that. Thank you, Congressman David G. Valadao, for supporting the —now is the time to move this critical legislation forward.

01/20/2026

Every delay means missed chances for early cancer detection. Congress must act NOW and pass the . Lives depend on it! David Valadao Congressman Raul Ruiz, MD US Rep Nanette Diaz Barragán Senator Adam Schiff

01/20/2026

Despite the CDC’s decision
to remove hepatitis A and B from infant vaccine recommendations, skipping the dose leaves people vulnerable to a lifelong risk of chronic liver disease and cancer.
Read more here:

Hepatitis B (HepB) is an infection of the liver that can lead to chronic disease requiring lifelong treatment and an increased risk of cancer and death.  People living with the […]

01/15/2026

Proud to stand with 550+ groups calling for passage of the . Congress cannot miss this opportunity to improve access. Leader John Thune, Senator Chuck Schumer, Speaker Mike Johnson, & Congressman Hakeem Jeffries

01/15/2026

Bill Remak, founder and CEO of the California Hepatitis C Task Force, urges policymakers to open access to more D-SNPs and allow qualified, high-performing plans to continue serving our state’s most vulnerable patients.
Read more here:

CalAIM, a broad alteration of Medi-Cal, eliminates choice for the people who need it most, writes Petaluma resident Bill Remak.

01/14/2026

New research from Yale School of Medicine shows that chronic hepatitis C infection may increase a person’s risk of developing pancreatic cancer.
Read more here:

A new study from Yale School of Medicine researchers found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in

01/13/2026

Birmingham researchers lead the world’s first trial for rare liver disease treatment, investigating whether a new medical device can slow disease progression.
Read more here:

The trial will investigate whether a new medical device, Carbalive, can slow disease progression of a rare liver disease

12/30/2025

Continued hepatitis B testing is needed in Canada to diagnose and treat asymptomatic patients before disease progression.
Read more here:

Sponsor Content

12/29/2025

Scientists have discovered that blocking the KHK enzyme may break the link between alcohol and liver disease.
Read more here:

Scientists discovered that alcohol activates a sugar-producing pathway in the body, creating fructose that may reinforce addictive drinking. The enzyme responsible, KHK, appears to drive both alcohol cravings and liver injury. When this enzyme was blocked in mice, their drinking decreased and their....